Claire Vanpouille-Box

Oct 28, 2024 | redjournal.org | Claire Vanpouille-Box

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes Oncology ScanVolume 121, Issue 2p283-286 ⁎Department of Radiation Oncology, Weill Cornell Medicine, New York †Sandra and Edward Meyer Cancer Center, New York Publication History: Received October 28, 2024; Accepted November 3, 2024 DOI:...

Oct 28, 2024 | redjournal.org | Claire Vanpouille-Box

Get full text accessLog in, subscribe or purchase for full access. ReferencesDe Martino, M ∙ Daviaud, C ∙ Vanpouille-Box, C. Radiotherapy: An immune response modifier for immuno-oncologySemin Immunol. 2021; 52, 101474De Martino, M ∙ Padilla, O ∙ Daviaud, C ... Exploiting radiation therapy to restore immune reactivity of glioblastomaFront Oncol. 2021; 11, 671044Galluzzi, L ∙ Aryankalayil, MJ ∙ Coleman, CN ... Emerging evidence for adapting radiotherapy to immunotherapyNat Rev Clin Oncol.

Mar 16, 2023 | cell.com | Claire Vanpouille-Box |Lorenzo Galluzzi

Mitochondrial outer membrane permeabilization (MOMP) is crucial for the cytosolic accumulation of mitochondrial DNA (mtDNA) species that are required to jumpstart innate and adaptive immunity. Recent data reported by Ghosh et al . suggest that tumor protein p53 regulates MOMP-dependent type I interferon (IFN) production, not only via MOMP-promoting effects, but also by directing mtDNA-degrading exonucleases to proteasomal processing.